Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CRISPR-Cas System: A Tool to Eliminate Drug-Resistant Gram-Negative Bacteria
Rajeshwari Rajesh Kundar, Karuna Gokarn
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1498-1498
Open Access | Times Cited: 20

Showing 20 citing articles:

CRISPR-Cas-Based Antimicrobials: Design, Challenges, and Bacterial Mechanisms of Resistance
Arianna Mayorga-Ramos, Johana Zúñiga-Miranda, Saskya E. Carrera-Pacheco, et al.
ACS Infectious Diseases (2023) Vol. 9, Iss. 7, pp. 1283-1302
Open Access | Times Cited: 43
Recent Advances in Understanding the Molecular Mechanisms of Multidrug Resistance and Novel Approaches of CRISPR/Cas9-Based Genome-Editing to Combat This Health Emergency
Khaled S. Allemailem
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 1125-1143
Open Access | Times Cited: 11
Emerging strategies and therapeutic innovations for combating drug resistance in Staphylococcus aureus strains: A comprehensive review
Mohanraj Gopikrishnan, Sree Haryini, C. George Priya Doss
Journal of Basic Microbiology (2024) Vol. 64, Iss. 5
Closed Access | Times Cited: 9
New Frontiers in CRISPR: Addressing Antimicrobial Resistance with Cas9, Cas12, Cas13, and Cas14
Ahmed S.A. Ali Agha, Ali Al‐Samydai, Talal Aburjai
Heliyon (2025) Vol. 11, Iss. 2, pp. e42013-e42013
Open Access
Integrons as the potential targets for combating multidrug resistance inEnterobacteriaceaeusing CRISPR- Cas9 technique
Varsha Prakash Shetty, Sadanand Dangari Akshay, Praveen Rai, et al.
Journal of Applied Microbiology (2023) Vol. 134, Iss. 7
Open Access | Times Cited: 15
Strategies to Overcome Antimicrobial Resistance in Nosocomial Infections, A Review and Update
Nasim Bakhtiyari, Safar Farajnia, Samaneh Ghasemali, et al.
Infectious Disorders - Drug Targets (2024) Vol. 24, Iss. 6
Closed Access | Times Cited: 4
Role of CRISPR-Cas systems and anti-CRISPR proteins in bacterial antibiotic resistance
Hiva Kadkhoda, Pourya Gholizadeh, Hossein Samadi Kafil, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e34692-e34692
Open Access | Times Cited: 4
CRISPR-Based Gene Editing in Acinetobacter baumannii to Combat Antimicrobial Resistance
Muhammad Junaid, Krit Thirapanmethee, Piyatip Khuntayaporn, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 920-920
Open Access | Times Cited: 8
A paper-based assay for detecting hypervirulent Klebsiella pnuemoniae using CRISPR-Cas13a system
Gargi Bhattacharjee, Nisarg Gohil, Khushal Khambhati, et al.
Microchemical Journal (2024) Vol. 203, pp. 110931-110931
Closed Access | Times Cited: 2
Engineering conjugative CRISPR-Cas9 systems for the targeted control of enteric pathogens and antibiotic resistance
Haiqing Sheng, Sarah Wu, Yansong Xue, et al.
PLoS ONE (2023) Vol. 18, Iss. 9, pp. e0291520-e0291520
Open Access | Times Cited: 5
Recent advances in gene-editing approaches for tackling antibiotic resistance threats: a review
Amani H. Al-Fadhli, Wafaa Jamal
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 1
From resistance to remedy: the role of clustered regularly interspaced short palindromic repeats system in combating antimicrobial resistance—a review
Ali Raza, Pakiza Fatima, Bushra Yasmeen, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 1
Design, potential and limitations of conjugation‐based antibacterial strategies
Elisabeth Derollez, Christian Lesterlin, Sarah Bigot
Microbial Biotechnology (2024) Vol. 17, Iss. 11
Open Access | Times Cited: 1
Application of CRISPR-Cas System to Mitigate Superbug Infections
Ali A. Rabaan, Mona A. Al Fares, Manar Almaghaslah, et al.
Microorganisms (2023) Vol. 11, Iss. 10, pp. 2404-2404
Open Access | Times Cited: 4
The Potential Role of Persister Cells in Urinary Tract Infections
Butool Durrani, Ashu Mohammad, Bernardita M. Ljubetic, et al.
Current Urology Reports (2023) Vol. 24, Iss. 11, pp. 541-551
Closed Access | Times Cited: 4
Can CRISPR/CAS Help Fight Multidrug Resistance (MDR) Bacterial Infections?
Ashwani Kumar, Akanksha Kumari, Neha Thakur, et al.
(2024), pp. 95-111
Closed Access
A Review: CRISPR Cas System and the Mechanism With an Inhibition of Binding of CRISPR Cas‐9
Akram Hosen, Md Nakibul Hasan Nishat, MD. Mohaimin Hossain Soaib, et al.
Nano Select (2024)
Open Access
Biochemistry and Future Perspectives of Antibiotic Resistance: An Eye on Active Natural Products
Giulia Caioni, Carolina P. Reyes, Davide Laurenti, et al.
Antibiotics (2024) Vol. 13, Iss. 11, pp. 1071-1071
Open Access
Rational Design of Antibacterial Agents for Multidrug‐Resistant Infections
Sathish Kumar Konidala, Podila Naresh, Risy Namratha Jamullamudi, et al.
(2024), pp. 403-421
Closed Access
Investigation of the Most Common Specimens in the Pediatric Hospital in Kirkuk and the Epidemiology of Predominant Bacteria Using Multiple Antibiotic Resistance Indices
Abbas Hameed Sh. Al-Wandawy, Luma Abdulhady Zwain
Archives of Clinical Infectious Diseases (2024) Vol. 20, Iss. 2
Open Access
Page 1

Scroll to top